# Indalo Therapeutics

Indalo Therapeutics is an Asset Manager based in St. Louis, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** St. Louis, United States
- **Region:** North America
- **Address:** St. Louis, MO, United States
- **Assets under management:** Undisclosed
- **Website:** indalotherapeutics.com

## Regulatory record

- **Reports private funds:** No

## About

Indalo Therapeutics is a preclinical-stage biotechnology company based in St. Louis, United States, founded in 2014. It has secured $11.8 million in total funding.

## Sectors

- Therapeutics
- Biotechnology

## Questions

### Who runs Indalo Therapeutics?

No named principals or leadership team members have been publicly identified for Indalo Therapeutics. The firm does not list management on a website or in any accessible publication as of mid-2026.

### How much capital does Indalo Therapeutics manage?

Indalo Therapeutics does not disclose AUM or deployment figures. No regulatory filings or press reports provide a capital estimate.

### What investment stages does Indalo Therapeutics target?

Indalo Therapeutics' investment focus has not been documented. It is unclear whether it makes direct investments, fund commitments, or operates as a therapeutic developer.

### Where can I find more information about Indalo Therapeutics?

The firm's website is indalotherapeutics.com, but no substantive content was scraped from it as of 2026. It does not have a public LinkedIn profile or appear in major industry databases.

## Related profiles

- [CoreOS](https://altss.com/profile/coreos)
- [Trans World Entertainment](https://altss.com/profile/trans-world-entertainment)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/indalo-therapeutics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology